During the past decade, Yan'an Hospital of Kunming City conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yan'an Hospital of Kunming City" #1 sponsor was "Chen Xiangmei" with 1 trials, followed by "Guangdong Provincial People's Hospital" with 1 trials sponsored, "Lifetech Scientific (Shenzhen) Co., Ltd." with 1 trials sponsored, "Pfizer Pharmaceuticals Ltd." with 1 trials sponsored and "Shanghai Zhongshan Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yan'an Hospital of Kunming City" #1 collaborator was "First Affiliated Hospital of Guangxi Medical University" with 2 trials as a collaborator, "Hainan People's Hospital" with 2 trials as a collaborator, "Peking University Shenzhen Hospital" with 2 trials as a collaborator, "Central South University" with 1 trials as a collaborator and "Changsha Central Hospital" with 1 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Yan'an Hospital of Kunming City" are "Abdominal Aortic Aneurysm" (1 trials), "B Cell Lymphoma" (1 trials), "B-cell Acute Lymphoblastic Leukemia" (1 trials), "Coronary Artery Disease" (1 trials) and "IgA Nephropathy" (1 trials). Many other conditions were trialed in "Yan'an Hospital of Kunming City" in a lesser frequency.

Most popular intervention types in "Yan'an Hospital of Kunming City" are "Drug" (2 trials), "Biological" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "16S rRNA gene sequencing of cervical secretions" (1 trials), "Abdominal Aortic Aneurysm Stent Graft System" (1 trials), "Abelmoschus manihot" (1 trials), "Anti-CD19 CAR-T Cells Injection" (1 trials) and "Huaiqihuang granules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yan'an Hospital of Kunming City" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yan'an Hospital of Kunming City". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yan'an Hospital of Kunming City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yan'an Hospital of Kunming City, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".